---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-298535"
form_type: "8-K"
ticker: "AURA"
cik: "0001501796"
company_name: "Aura Biosciences, Inc."
filed_at: "2022-12-05T23:59:59+00:00"
generated_at: "2026-06-21T09:31:07.099668+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aura Biosciences raises $86.7M in public offering of 7.7M shares at $12.00/share

## Summary
- Net proceeds of ~$86.7M from 7.705M shares (including full overallotment) at $12.00 per share.
- Proceeds to advance belzupacap sarotalocan for choroidal melanoma and NMIBC, plus platform and corporate.
- Management expects cash runway to fund operations into 2025.
- Offering closed Dec 5, 2022; underwriters led by SVB Securities, Cowen, Evercore.

## SEC filing metadata
- accession: 0001193125-22-298535
- form_type: 8-K
- ticker: AURA
- cik: 0001501796
- company_name: Aura Biosciences, Inc.
- filed_at: 2022-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501796/000119312522298535/0001193125-22-298535-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501796/000119312522298535/d393902d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-298535
- JSON: https://secwatch.observer/filing/0001193125-22-298535.json
- Plain text: https://secwatch.observer/filing/0001193125-22-298535.txt

## Key facts
- Material Agreements
  Aura Biosciences, Inc. entered into Underwriting Agreement with SVB Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C valued at 6,700,000 shares of common stock at $12.00 per share, with option for additional 1,005,000 shares (effective 2022-11-30).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: SVB Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C
  - Value: 6,700,000 shares of common stock at $12.00 per share, with option for additional 1,005,000 shares
  - Effective: 2022-11-30
  source text: On November 30, 2022, Aura Biosciences, Inc. (the “Company”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with SVB Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C, as representatives of the several underwriters named therein (the “ Underwriters ”), pursuant to which the Company agreed to issue and sell 6,700,000 shares of the Company’s common stock, par value $0.00001 per share (the “ Common Stock ”), to the Underwriters at a public offering price of $12.00 per share (the “ Offering ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501796/000119312522298535/0001193125-22-298535-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.